Summary Safety Review - MELATONIN (N-acetyl-5-methoxytryptamine) - Review of the Safety of Melatonin in Children and Adolescents (French, HTML)
Summary Safety Review - MELATONIN (N-acetyl-5-methoxytryptamine) - Review of the Safety of Melatonin in Children and Adolescents: French HTML file. From Health Canada, updated May 2024. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2024-05-09
After becoming aware of international reports about neurological side effects, such as anxiety, panic reaction, visual hallucinations and seizures, possibly associated with melatonin use in children and adolescents ranging from newborn to 18 years old (pediatric population), Health Canada did a review of this safety issue in this age group.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file